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Background: Risk factor control after a coronary event in a recent European multi-centre study was inadequate.
Patient selection from academic centres and low participation rate, however, may underscore failing risk factor
control in routine clinical practice. Improved understanding of the patient factors that influence risk factor control is
needed to improve secondary preventive strategies. The objective of the present paper was to determine control of
the major risk factors in a coronary population from routine clinical practice, and how risk factor control was influenced
by the study factors age, gender, number of coronary events, and time since the index event.
Methods: A cross-sectional study determined risk factor control and its association with study factors in 1127 patients
(83% participated) aged 18-80 years with acute myocardial infarction and/or revascularization identified from medical
records. Study data were collected from a self-report questionnaire, clinical examination, and blood samples after 2-36
months (median 16) follow-up.
Results: Twenty-one percent were current smokers at follow-up. Of those smoking at the index event 56% continued
smoking. Obesity was found in 34%, and 60% were physically inactive. Although 93% were taking blood-pressure
lowering agents and statins, 46% were still hypertensive and 57% had LDL cholesterol >1.8 mmol/L at follow-up.
Suboptimal control of diabetes was found in 59%. The patients failed on average to control three of the six major risk
factors, and patients with >1 coronary events (p < 0.001) showed the poorest overall control. A linear increase in
smoking (p < 0.01) and obesity (p < 0.05) with increasing time since the event was observed.
Conclusions: The majority of coronary patients in a representative Norwegian population did not achieve risk factor
control, and the poorest overall control was found in patients with several coronary events. New strategies for
secondary prevention are clearly needed to improve risk factor control. Even modest advances will provide major
health benefits.
Trial registration: Registered at ClinicalTrials.gov (ID NCT02309255).
Keywords: Secondary prevention, Coronary heart disease, Risk factors, GuidelinesBackground
Over the recent years, there has been a decline in mor-
tality rates worldwide [1] leaving a large number of
coronary heart disease (CHD) patients in need of opti-
mal secondary prevention. A positive trend in acute
myocardial event rates and recurrences from 1994-2009
were also found in Norway [2]. The association between
modifiable risk factors and CHD is overwhelmingly doc-
umented [3], likewise the benefit of achieving risk factor* Correspondence: elisbj@vestreviken.no
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Despite evidence-based guidelines [5] and cardiac
rehabilitation programs for more than 20 years, the
EuroAspire studies revealed that the implementation of
secondary prevention is far from optimal, with increas-
ing prevalence of smoking in patients <50 years, physical
inactivity, obesity and diabetes [6, 7]. In the European
cohort of the REACH Study (2003-2004), 40% of symp-
tomatic cardiovascular disease patients had poor control
of at least three of the five risk factors assessed [8]. In
the Clarify study conducted a decade later, somele is distributed under the terms of the Creative Commons Attribution 4.0
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region, 50% did not achieve risk factor control [9].
Even though the abovementioned studies provide valu-
able data on the quality of secondary prevention, patient
selection could potentially be a matter of concern. In
EuroAspire IV [6] patient inclusion was conducted
mainly from academic centres, with potentially better
secondary prevention than general cardiac practice.
Furthermore, the average interview rate was 49%, and
the remaining non-participants were probably more
likely to have an even poorer risk factor control. In other
multinational studies [9–11], patient identification and
inclusion has been conducted at outpatient clinics, often
specialist centres, and patients attending them may be
more concerned about their health. Previous prevalence
estimates thus most likely overestimate adherence to
guidelines in the general population of CHD patients.
Estimates based on studies of everyday clinical practice
are clearly needed.
The reasons for unhealthy lifestyle and low risk factor
control are complex and poorly understood and the
identification of patient and healthcare factors of import-
ance for coronary risk profile remains a public health
priority [5]. The overall aim of the The NORwegian
CORonary (NOR-COR) Prevention Study is to identify
medical, and psychosocial factors associated with
unfavourable risk factor control after a cardiovascular
event. The present paper determines control of the six
major coronary risk factors based in routine clinical
practice, and identifies the influence of age, gender, num-
ber of coronary events, and time since the index event.Methods
Design and population
The design, methods, and baseline characteristics of the
NOR-COR Study have been described elsewhere [12].
Briefly, 1789 consecutive patients aged 18-80 years with
a first or recurrent coronary event defined as acute myo-
cardial infarction, coronary artery by-pass graft oper-
ation, or percutaneous coronary intervention (PCI) were
identified from hospital discharge lists from 2011-14. In
patients with recurrent coronary events, the index event
was defined as the last event recorded prior to the time
of study inclusion. Of these patients, 423 were excluded
due to cognitive impairment (n = 28), psychosis (n = 18),
drug abuse (n = 10), short life expectancy (n = 136), dead
(n = 160), not able to understand Norwegian (n = 44),
and other (n = 27). Of the remaining 1366 invited
patients, 1127 (83%) participated in attending a clinical
visit and completing a comprehensive questionnaire [12]
after 2-36 months (median 16) follow-up. The frequency
of missing values for the questionnaire based data was
low, within the range from 0 - 10%.The study was conducted at two Norwegian hospitals
(Drammen and Vestfold) with a total catchment of
380,000 inhabitants corresponding to 7.4% of the
Norwegian population. The catchment area has a
representative blend of city and rural districts and is rep-
resentative of Norwegian geography, economy, age dis-
tribution, morbidity, and mortality [13]. The cardiac
rehabilitation program at Drammen Hospital includes a
multi-disciplinary one day “heart school”, and exercise
training twice per week for 6 weeks. The Hospital of
Vestfold provides comprehensive lifestyle intervention
described elsewhere [14].
Ethics, consent and permission
The study was approved by the Regional Committee of
Ethics in Medical Research. All patients signed a written
informed consent prior to study participation.
Study assessments
Medication and co-morbidity at the index event were
registered from the hospital medical records. Cardio-
vascular medication, risk factors and study factors at
follow-up were obtained from the self-report ques-
tionnaire, the clinical examination and blood-samples.
All blood samples were analysed at Drammen hos-
pital. Diet was assessed by a brief diet questionnaire
including seven selected quantitative questions (the
frequency of intake of different types of foods and
beverages). These questions have been validated
against intake of matching food groups [15]. Time
since the index coronary event was calculated from
index event to the date of study inclusion. Low edu-
cation was defined by completion of primary- and
secondary school only.
Major coronary risk factors
 Smoking: categorized as current, former or never.
 Overweight and obesity: Body weight was measured
in light clothes without shoes (SECA 813, DE).
Height was measured using a wall fixed mechanical
measuring rod (SECA 264, DE). Overweight and
obesity was defined as body mass index (BMI)
>25 kg/m2 and >30 kg/m2, respectively. Waist
circumference was measured with a non-stretchable
tape (SECA 201, DE). A waist circumference above
94 cm and 102 cm in men and above 80 cm and
88 cm in women was defined as central overweight
and obesity, respectively.
 Physical activity: assessed by frequency (never, <1
time weekly, 1 time weekly, 2-3 times weekly and
almost every day), intensity (light, medium and
vigorous), and duration (<15 min, 15-29 min, 30-60
min and >60 min). Low physical activity was defined
Table 1 Characteristics of the patients (n = 1127) at the time of
the index coronary event




ST-elevation infarction (%) 30
Non ST-elevation infarction (%) 50
Stable or unstable angina (%) 20
More than 1 coronary event (%) 30
Angiographic findings
No significant stenoses (%) 6
Singel vessel disease (%) 55
Multi-vessels disease (%) 39
Intervention
PCIa with stent (%) 75
PCIa without stent (%) 2
Coronary artery bypass graft operation (%) 13
No intervention (%) 10
Previous or ongoing participation in cardiac rehabilitation (%) 50
Co-morbidity
Hypertension (%) 43
Diabetes type I or II (%) 17
Heart failure (%) 13
Atrial fibrillation (%) 9
Stroke or transitory ischemic attack (%) 7
Peripheral artery disease (%) 9
Medication at discharge after the index event
Aspirin (%) 99
Other antiplateles (%) 88
Statins (%) 96
Beta blockers (%) 85
ACE inhibitors or ARBb (%) 56




Wafarin or NOACc (%) 7
All information was obtained from the hospital medical records
aPercutaneous coronary intervention, bACE, angiotensin converting enzyme;
ARB, angiotensin receptor blocker. cNOAC, new oral anticoagulants
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times a week.
 Blood Pressure (BP) control: BP was measured after
standard procedures using aWelch Allyn digital
sphygmomanometer. Unfavourable BP control was
defined as BP > 140/90 mmHg (>140/80 mmHg in
diabetics).
 Blood-sugar control: assessed by HbA1c analysed -
Tosoh G8, Ca, US. Unfavourable blood sugar
control was defined as HbA1c ≥6.1% (non-diabetics)
and >7.0% (diabetics) [5].
 Low density lipoprotein (LDL) cholesterol: analysed -
Architect ci16200, Ca, US. Elevated LDL cholesterol
was defined > 1.8 mmol/l [5].
Statistics
Statistical analyses have been performed using SPSS ver-
sion 21. Parametric descriptive statistics were applied.
Binary logistic regression analysis was used to calculate
odds ratios (ORs) for unfavourable risk factor control
and adjusted for age, gender, number of coronary events,
and time since the index event.
General Linear Model (ANCOVA) was used to esti-
mate marginal means for number of unfavourable risk
factors (smoking, BMI, physical inactivity, BP, LDL chol-
esterol, and HbA1c) by age, gender and number of
coronary events with all independents controlled as
dummies simultaneously, and with time since event
entered as a linear covariate.
Results
Baseline characteristics are presented in Table 1.
Myocardial infarction and stable CHD was the index
event in 80% and 20% of the patients, respectively.
Angiography was performed in all patients but one,
and 90% were revascularized. Patients with >1 coron-
ary event amounted to 30% with a median number of
events of 2 (range 2-11). In this group, the proportion
of patients with diabetes was more than twice that
seen among those with one event only (28% vs. 12%,
p < 0,001).
The prescription rate of recommended preventive
drugs [5] was high at discharge. All the patients treated
with PCI were prescribed dual anti-platelet treatment.
At follow-up, there was a small reduction in the use
of beta-blockers (from 85 to 72%) and angiotensin
converting enzyme inhibitor (ACEI)/angiotensin receptor
blocker (ARB) (from 56 to 50%), while the proportions
that used at least one statin (93%) and anti-platelet agent
(97%) were almost identical. At the time of follow-up, 50%
of the patients had attended cardiac rehabilitation.
The proportion of unfavourable risk factors at follow-
up was high (Fig. 1). Of those who smoked at baseline,
56% continued to do so. The majority of patients (84%)had an increased waist circumference, and 60% had cen-
tral obesity. Ninety-three per cent of the patients used at
least one BP lowering drug at discharge after the index
event (Table 1), and the same percentage reported use of
statin at follow-up. However, the frequency of elevated
BP and LDL cholesterol at follow-up were still high. Of
the diabetic patients 59% had HbA1c >7% although 79%
Fig. 1 Proportion of coronary risk factors 2-36 months after the index coronary event
Sverre et al. BMC Cardiovascular Disorders  (2017) 17:40 Page 4 of 8used blood sugar lowering medication. In patients with-
out known diabetes, 21% had an HbA1c value ≥6.1%
and of these patients 8% had HbA1c ≥6.5% indicating
diabetes [16]. The proportion that reported to eat fish
less than 3 times a week was 46%, while 62% ate fruits
or vegetables less than two times daily, and 40% less
than once daily.
Current smoking (25% vs. 12%, p < 0.001) and physical
inactivity (64% vs 34%, p < 0.001) were significantly more
frequent in patients with low vs. high education, while
overweight, unfavorably blood pressure, blood glucose
and LDL cholesterol control were not.
The estimated marginal means for number of un-
favourable risk factors [5] by gender, age and number of
coronary events are shown in Fig. 2. On average, the
patients had three of the six measured risk factors not at
target according to guideline recommendations [5]. Less
than 2% achieved control for all risk factors, while 62%
had three or more unfavourable risk factors. Patients
with more than one coronary event (β 0.43, p < 0.001)
had the poorest overall risk factor control.
Multi-adjusted odds ratios (OR) for unfavourable cor-
onary risk factors at follow-up by age, gender, number of
coronary events, and time since the index event are
shown in Additional file 1. Current smoking (p < 0.001),
obesity (p < 0.001) and elevated HbA1c (p < 0.01) were
significantly more frequent in the younger patients,
while inadequate BP control (p < 0.001) was more fre-
quent with increasing age. ORs for current smoking, low
physical activity, and LDL >1.8 mmol/l were significantly
higher in women compared to men. ORs for lowphysical activity, obesity, and elevated LDL cholesterol
were significantly higher in patients with several coron-
ary events. There were no significant differences in ORs
between the four time groups since the index event, but
for smoking (p < 0.01) and obesity (p < 0.05) the test for
linear trend was statistically significant with reduction in
risk factor control with increasing time since the event.
Discussion
Of the CHD patients included from a high income coun-
try with a well-developed health care system [17], the
majority had a poor risk factor control and thus did not
achieve adequate secondary prevention. There were high
proportions of current smoking, obesity and physical
inactivity. Blood pressure, cholesterol and blood sugar
control were inadequate despite the high reported use of
medications. Only a minority of patients (<2%) fulfilled
the guidelines recommendations [5] for all coronary risk
factors, and more than half of them had inadequate con-
trol of three or more risk factors. The measured study
factors influenced risk factor control with the poorest
overall lifestyle control in the youngest patients. Patients
with several previous CHD events had the poorest over-
all coronary risk factor control. There was a higher
prevalence of smoking and obesity with increasing time
since the since the coronary event.
There are certain limitations of the study. First, the cor-
onary risk factors and study factors were measured at one
point in time and thus are prone to measurement and re-
call bias. Moreover, diet is calculated by a semi-quantitative
measure, only. Our questions about physical activity have
Fig. 2 Estimated marginal means* of number of coronary risk factors†
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close as possible to guidelines recommendations. Informa-
tion about the number and the different types of antiplate-
let agents at follow-up is not available. The routine clinical
setting and the high participation rate (83%) are important
strengths of the study. The time span from the index event
to follow-up was 2-36 months allowing us to assess how
time influences risk factor control. This might impose a
selection bias by survival effect. The contribution of ex-
cluded patients due to death and short life expectancy is,
however, quite similar among the groups with an index
event within one year (33%), two years (34%), and three
years (33%), respectively, prior to inclusion. Thus, the risk
for bias by survival should be minor.
The latest EuroAspire Study [6] had similar inclusion
criteria and age distribution as the NOR-COR Study,
and in comparison they found a higher proportion of
LDL cholesterol >1.8 mmol/l (81% vs. 57%) and diabetes
(27% vs. 17%), but fewer diabetic patients had HbA1c
>7% (48% vs. 59%). Low physical activity was defined dif-
ferently, but both studies showed that low physical activ-
ity was predominant (60% vs. 60%). The frequencies of
hypertension (43% vs. 46%), obesity (38% vs. 34%), and
central obesity (58% vs. 60%) were quite similar. The
proportion of current smoking was significantly higher
(21%) in our CHD population compared to both
EuroAspire IV [6] (16%), and other international stud-
ies [9–11, 19] (12-18%). Statistics from OECD indi-
cate a lower prevalence in Norway versus average EU
regarding smoking (19% vs. 23% [average EU]) [20]and obesity (10% vs. 18% [OECD average]) [21]. It is
therefore a paradox that a higher rate of smoking was
found among CHD patients in Norway compared to
Europe, while the rate of obesity was quite similar. This
paradox can be explained by the aforementioned risk of
selection bias [6, 7] and by the contribution of non-
responders. In the present study with high participation
rate from routine clinical practice, these factors are to a
higher degree accounted for. There is an ample risk that
previous studies [6, 7] have underestimated the prevalence
of smoking and obesity in CHD patients.
We found a higher use of anti-platelets (97% vs. 94%),
and statins (93% vs. 86%), but lower use of beta-blockers
(72% vs. 83%) and ACEI/ARBs (50% vs. 75%) compared
with EuroAspire IV [6]. However, there were significant
differences in the use of these drugs in various European
countries [6].
Large studies from different regions worldwide have
also demonstrated that 30-80% of CHD patients had
diabetes, were obese, and had LDL cholesterol and
BP above the recommended targets [9–11]. In the
REACH Registry, one-year risk of subsequent cardio-
vascular events was inversely related to risk factor
control [22], emphasizing the importance of reaching
these treatment goals.
The reasons for the low adherence to secondary pre-
vention are complex and multi-factorial [5, 23]. Low
socioeconomic status is known to affect both risk factor
control and the course of CHD negatively [24, 25], and
we confirmed the well-known association between low
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such as anxiety, depression, type-d personality and lack
of social support may affect both etiological factors, life-
style and adherence, and are associated with adverse
outcomes in CHD patients [26]. Furthermore many
revascularized patients have no symptoms. In a recent
post PCI study, many patients perceived that they were
cured from their CHD [27]. Few reported lifestyle-style
factors as being causal, and almost 40% perceived no
need for lifestyle changes. Patients’ understanding of
CHD and CHD risk factors have been shown to be
insufficient [28]. Furthermore, many patients attribute
their disease to factors they cannot influence [27] like
age and family history, that may partly explain lack of
motivation to change lifestyle and adhere to their med-
ical regimen. Despite overwhelming documentation of
the benefits of secondary preventive drug [5], a meta-
analysis revealed that only 60% of CHD patients had
good adherence to cardiovascular medication [29]. Poor
adherence with medication may in part explain why
many patients do not reach treatment targets for BP,
cholesterol and blood sugar. When the vast majority of
patients were prescribed cholesterol and BP lowering
drugs, and only 40-55% reached treatment targets, it is
possible that the drugs chosen were not the optimal, the
dosages applied were too low, the patients were not
compliant or a combination. The clinical significance of
long-term dual anti-platelet therapy after coronary stent
procedures was recently documented in CHD [30],
reflecting the need for improved secondary prevention
programs that also address drug-adherence reliability
and over time (>12 months).
The youngest patients had the highest proportion of
unfavourable lifestyle factors, and this might have con-
tributed to an early onset of CHD. The positive trend in
acute myocardial infarction event rates and recurrences
from 1994-2009 in Norway were mostly seen among pa-
tients older than 65 years, whereas less favourable trends
were observed among younger patients, in particular
women [2]. This is concerning, and may be due to the
particular poor risk factor control in this sub-group as
demonstrated in the present study. Correspondingly, the
poor risk factor control in patients with more than one
coronary event might be why they suffer repeated
events. It is concerning that the success of secondary
prevention in these high-risk patients is that poor. The
effect of lifestyle intervention programs on risk factor
control and subsequent events is well documented
[14, 31]. In the present study, only half of the pa-
tients attended the available programs. The participa-
tion rates in cardiac rehabilitation programs range
between 30-60% in Europe, lowest among the oldest
patients, and those with co-morbidity [7, 32].
Underutilization of effective preventive programs orimplementation of programs that do not result in ad-
herence in routine clinical practice, may contribute to
poor risk factor control. The higher proportion of
current smokers and obese patients with increasing
time since the coronary event underline the need for
more long-lasting secondary preventive programs [33].
Medical and psychosocial factors may act as barriers
to lifestyle changes, treatment adherence and may mod-
erate the effects of cardiac rehabilitation [26]. The pre-
dictors of good adherence to risk factor control are
likely to differ by patient characteristics and risk factors,
indicating a need for more tailored interventions [34].
Accordingly, we found different impact of age, gender,
education, time since the event, and the number of events
on the major risk factors. In the further studies, we aim to
explore the relative importance of a number of potentially
modifiable factors on risk factor control [12].
Conclusion
The majority of CHD patients from a routine clinical
practice in a representative Norwegian population did
not achieve control of the major coronary risk factors.
The measured non-modifiable study factors had differ-
ent impact on the risk factors, and the poorest overall
control was found in patients with several coronary
events. It is concerning that secondary prevention of
CHD fails in a country with a well-developed health care
system. Further knowledge about factors associated with
poor risk factor control and strategies for implementa-
tion of these factors are strongly needed to improve sec-
ondary prevention. Even modest advances will provide
major health benefits.
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